Anhydrous Citric Acid Monograph

Stage 6 Harmonization
Official August 1, 2012
Citric 1
Anhydrous Citric Acid

Portions of the monograph text that are national USP text,
and are not part of the harmonized text, are marked
with symbols () to specify this fact.
C6H8O7
1,2,3-Propanetricarboxylic acid, 2-hydroxy-;
Citric acid [77-92-9].
192.1
DEFINITION
Anhydrous Citric Acid contains NLT 99.5% and NMT
100.5% of C6H8O7, calculated on the anhydrous basis.
IDENTIFICATION
A. INFRARED ABSORPTION 197K: Dry the substance to
be examined at 105 for 2 h.
ASSAY
PROCEDURE
Sample: 0.550 g of Anhydrous Citric Acid; record
weight accurately.
Analysis: Dissolve the Sample in 50 mL of water. Add
0.5 mL of phenolphthalein TS. Titrate with 1 N sodium
hydroxide VS. Each mL of 1 N sodium hydroxide is
equivalent to 64.03 mg of C6H8O7.
Acceptance criteria: 99.5%100.5% on the anhydrous
basis
IMPURITIES
RESIDUE ON IGNITION 281: NMT 0.1%, determined on
1.0 g
HEAVY METALS 231: NMT 10 g/g
SULFATE
Standard sulfate solution A: 1.81 mg/mL of potassium
sulfate in 30% alcohol. Immediately before use, transfer
10.0 mL of this solution to a 1000-mL volumetric flask,
dilute with 30% alcohol to volume, and mix. This solution contains 10 g/mL of sulfate.
Standard sulfate solution B: 1.81 mg/mL of potassium
sulfate in water. Immediately before use, transfer 10.0
mL of this solution to a 1000-mL volumetric flask, dilute
with water to volume, and mix. This solution contains
10 g/mL of sulfate.
Sample stock solution: 66.7 mg/mL of Anhydrous Citric Acid
Sample solution: To 4.5 mL of Standard sulfate solution
A, add 3 mL of a barium chloride solution (1 in 4),
shake, and allow to stand for 1 min. To 2.5 mL of the
resulting suspension, add 15 mL of the Sample stock solution and 0.5 mL of 5 N acetic acid, and mix.
Standard solution: Prepare as directed for the Sample
solution, except use 15 mL of Standard sulfate solution B
instead of the Sample stock solution.
Analysis
Samples: Sample solution and Standard solution
Acceptance criteria: Any turbidity produced in the
Sample solution after 5 min standing is not greater than
that produced in the Standard solution (0.015%).
LIMIT OF ALUMINUM (where it is labeled as intended for
use in dialysis)
Standard aluminum solution: To 352 mg of aluminum
potassium sulfate in a 100-mL volumetric flask, add a
few mL of water, swirl to dissolve, add 10 mL of diluted
sulfuric acid, dilute with water to volume, and mix. Im-
mediately before use, dilute 1.0 mL of this solution with

water to 100.0 mL.
pH 6.0 acetate buffer: Dissolve 50 g of ammonium
acetate in 150 mL of water, adjust with glacial acetic
acid to a pH of 6.0, dilute with water to 250 mL, and
mix.
Sample solution: Dissolve 20.0 g of Anhydrous Citric
Acid in 100 mL of water, and add 10 mL of pH 6.0
acetate buffer. Extract this solution with successive portions of 20, 20, and 10 mL of a 0.5% solution of 8hydroxyquinoline in chloroform, combining the chloroform extracts in a 50-mL volumetric flask. Dilute the
combined extracts with chloroform to volume, and mix.
Standard solution: Prepare a mixture of 2.0 mL of
Standard aluminum solution, 10 mL of pH 6.0 acetate
buffer, and 98 mL of water. Extract this mixture as described for the Sample solution, dilute the combined extracts with chloroform to volume, and mix.
Blank solution: Prepare a mixture of 10 mL of pH 6.0
acetate buffer and 100 mL of water. Extract this mixture
as described for Sample solution, dilute the combined
extracts with chloroform to volume, and mix.
Fluorometric conditions
Excitation wavelength: 392 nm
Emission wavelength: 518 nm
Analysis
Determine the fluorescence intensities of the Samples in
a fluorometer set as directed under Fluorometric conditions, using the Blank solution to set the instrument to
zero.
Acceptance criteria: The fluorescence of the Sample solution does not exceed that of the Standard solution (0.2
ppm).
Change to read:
LIMIT OF OXALIC ACID

Sample stock solution: 0.80 g of Anhydrous Citric
Acid in 4 mL of water1S (USP35)
Sample solution: To 1S (USP35) the Sample stock solution
add 3 mL of hydrochloric acid and 1 g of granular zinc,
boil for 1 min, and allow to stand for 2 min. Transfer
the supernatant to a test tube containing 0.25 mL of a
phenylhydrazine hydrochloride solution (1 in 100), and
heat to boiling. Cool rapidly, transfer to a graduated
cylinder, and add an equal volume of hydrochloric acid
and 0.25 mL of a potassium ferricyanide solution (1 in
20). Shake, and allow to stand for 30 min.
Standard solution: Prepare as directed for the Sample
solution, except use 4 mL of 0.10 mg/mL oxalic acid
solution, equivalent to 0.0714 mg/mL of anhydrous oxalic acid, instead of the Sample stock solution. [NOTE
Prepare concomitantly with the Sample solution.]
Analysis
Acceptance criteria: Any pink color produced in the
Sample solution is not more intense than that produced
in the Standard solution (0.036%).
SPECIFIC TESTS
BACTERIAL ENDOTOXINS TEST 85: The level of bacterial
endotoxins is such that the requirement in the relevant
dosage form monograph(s) in which Anhydrous Citric
Acid is used can be met. Where the label states that
Anhydrous Citric Acid must be subjected to further processing during the preparation of injectable dosage
forms, the level of bacterial endotoxins is such that the
requirement in the relevant dosage form monograph(s)
in which Anhydrous Citric Acid is used can be met.
2011 The United States Pharmacopeial Convention All Rights Reserved.
Citric
Change to read:
CLARITY OF SOLUTION
[NOTEThe Sample solution is to be compared to Standard suspension A in diffused daylight 5 min after preparation of Standard suspension A.]
Hydrazine sulfate solution: 10 mg/mL of hydrazine sulfate in water. Allow to stand for 46 h before use.
Methenamine solution: Transfer 2.5 g of methenamine
to a 100-mL glass-stoppered flask, add 25.0 mL of
water, insert the glass stopper, and mix to dissolve.
Primary opalescent suspension: Transfer 25.0 mL of
Hydrazine sulfate solution to the 1S (USP35) Methenamine
solution in the 100-mL glass-stoppered flask. Mix, and
allow to stand for 24 h. [NOTEThis suspension is stable
for 2 months, provided it is stored in a glass container
free from surface defects. The suspension must not adhere to the glass and must be well mixed before use.]
Opalescence standard: Dilute 15.0 mL of Primary opalescent suspension with water to 1000 mL. [NOTEThis
suspension should not be used beyond 24 h after
preparation.]
Standard suspension A: Dilute 5.0 mL of Opalescence
standard with 95 mL of water.1S (USP35)
Standard suspension B: Dilute 10.0 mL of Opalescence
standard with 90 mL of water.1S (USP35)
Sample solution: 200 mg/mL of Anhydrous Citric Acid
in water
Analysis
Samples: Standard suspension A, Standard suspension B,
water, and Sample solution
Transfer a sufficient portion of the Sample solution to a
test tube of colorless, transparent, neutral glass with a
flat base and an internal diameter of 1525 mm to
obtain a depth of 40 mm. Similarly transfer portions of
Standard suspension A, Standard suspension B, and
water to separate matching test tubes. Compare the
Sample solution, Standard suspension A, Standard suspension B, and water in diffused daylight, viewing vertically against a black background (see Spectrophotometry and Light-Scattering 851, Visual Comparison).
[NOTEThe diffusion of light must be such that Standard suspension A can readily be distinguished from
water, and that Standard suspension B can readily be
distinguished from Standard suspension A.]
Acceptance criteria: The Sample solution shows the
same clarity as that of water or its opalescence is not
more pronounced than Standard suspension A.1S (USP35)
Change to read:
COLOR OF SOLUTION
Standard stock solution A: Ferric chloride CS, cobaltous chloride CS, and dilute hydrochloric acid (10 g/L)
(2.4: 0.6: 7.0)
Standard stock solution B: Ferric chloride CS, cobaltous chloride CS, cupric sulfate CS, and dilute hydrochloric acid (10 g/L) (2.4: 1.0: 0.4: 6.2)
Standard stock solution C: Ferric chloride CS, cobaltous chloride CS, and cupric sulfate CS (9.6: 0.2: 0.2)
[NOTEPrepare the Standard solutions immediately
before use.]
Standard solution A: Dilute 2.5 mL of Standard stock
solution A with dilute hydrochloric acid (10 g/L) to 100
mL.
Standard solution B: Dilute 2.5 mL of Standard stock
solution B with dilute hydrochloric acid to (10 g/L) 100
mL.
Standard solution C: Dilute 0.75 mL of Standard stock

solution C with dilute hydrochloric acid (10 g/L) to 100
mL.
Sample solution: Prepare as directed in the test for
Clarity of Solution.
Analysis 1
Samples: Water and Sample solution
Transfer a sufficient portion of the Sample solution to a
test tube of colorless, transparent, neutral glass with a
flat base and an internal diameter of 1525 mm to
obtain a depth of 40 mm. Similarly transfer water to a
separate matching test tube. Compare the Sample solution and water in diffused daylight, viewing vertically
against a white background (see Spectrophotometry and
Light-Scattering 851, Visual Comparison).
Acceptance criteria 1: The Sample solution is not more
intensely colored than water. If more intensely colored,
follow Analysis 2.
Analysis 2
Samples: Standard solution A, Standard solution B, Standard solution C, and Sample solution
Transfer a sufficient portion of Standard solution A, Standard solution B, and Standard solution C to separate test
tubes of colorless, transparent, neutral glass with a flat
base and an internal diameter of 1525 mm to obtain
a depth of 40 mm. Compare the Sample solution from
Analysis 1 to Standard solution A, Standard solution B,
and Standard solution C in diffused daylight, viewing
vertically against a white background (see Spectrophotometry and Light-Scattering 851, Visual Comparison).
Acceptance criteria 2: The Sample solution is not more
intensely colored than Standard solutions A, B, and
C.1S (USP35)
READILY CARBONIZABLE SUBSTANCES
Sample: 1.0 g of powdered Anhydrous Citric Acid
Analysis: Transfer the Sample to a 22-mm 175-mm
test tube previously rinsed with 10 mL of sulfuric acid
and allowed to drain for 10 min. Add 10 mL of sulfuric
acid, agitate until solution is complete, and immerse in
a water bath at 90 1 for 60 0.5 min, keeping the
level of the acid below the level of the water during the
entire period. Cool the tube in running water, and
transfer the acid to a color-comparison tube.
Acceptance criteria: The color of the acid is not darker
than that of a similar volume of Matching Fluid K (see
Color and Achromicity 631) in a matching tube, the
tubes being observed vertically against a white
background.
STERILITY TESTS 71: Where the label states that Anhydrous Citric Acid is sterile, it meets the requirements for
Sterility Tests 71 in the relevant dosage form
monograph(s) in which Anhydrous Citric Acid is used.
Change to read:
WATER DETERMINATION, Method I 921:

Sample: 2.0 g of Anhydrous Citric Acid
1S (USP35)
Acceptance criteria: NMT 1.0%
ADDITIONAL REQUIREMENTS
PACKAGING AND STORAGE: Preserve in tight containers.
No storage requirements specified.
LABELING: Where it is intended for use in dialysis solutions, it is so labeled. Where Anhydrous Citric Acid must
be subjected to further processing during the preparation of injectable dosage forms to ensure acceptable levels of bacterial endotoxins, it is so labeled. Where Anhydrous Citric Acid is sterile, it is so labeled.
Citric 3
USP REFERENCE STANDARDS 11

USP Citric Acid RS
USP Endotoxin RS

Anhydrous Citric Acid Monograph

Uploaded by

Copyright:

Available Formats

Anhydrous Citric Acid Monograph

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Anhydrous Citric Acid Monograph

Uploaded by

Copyright:

Available Formats

Stage 6 Harmonization

Official August 1, 2012

Anhydrous Citric Acid

mediately before use, dilute 1.0 mL of this solution with

LIMIT OF OXALIC ACID

2011 The United States Pharmacopeial Convention All Rights Reserved.

Standard solution C: Dilute 0.75 mL of Standard stock

WATER DETERMINATION, Method I 921:

2011 The United States Pharmacopeial Convention All Rights Reserved.

USP REFERENCE STANDARDS 11

2011 The United States Pharmacopeial Convention All Rights Reserved.

You might also like